# Rapport Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/rapport-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 34 |
| Claims under review | 1 |
| Evidence records | 9 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-17T04:46:07.749004+00:00 |
| Last reviewed | 2026-10-17T04:46:07.749004+00:00 |

## Identity

- Legal name: Rapport Therapeutics, Inc.
- Display name: Rapport Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-17T06:11:08.855142+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.84 |
| Directors | 8 |
| Committees | 4 |
| Governance events | 14 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Abraham N. Ceesay, M.B.A.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:5
- James I. Healy: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. Committees: AUDIT COMMITTEE (member); compensation committee (chair). claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:6
- John Maraganore: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: AUDIT COMMITTEE (member); compensation committee (member). claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:7
- Raymond Sanchez: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: compensation committee (member); science and technology committee (member). claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:8
- Reid Huber: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. Committees: science and technology committee (member). claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:9
- Robert J. Perez: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: compensation committee (member); nominating and corporate governance committee (chair). claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:10
- Steven M. Paul: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-23. Committees: nominating and corporate governance committee (member); science and technology committee (member). claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:11
- Wendy B. Young: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: science and technology committee (chair). claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:12

## Committees

- AUDIT COMMITTEE (audit). Chair: NOT_PUBLISHED. Members: James I. Healy (member, current); John Maraganore (member, current). committee_id=alpha:committee:rapport-therapeutics-inc:audit-committee
- compensation committee (compensation). Chair: James I. Healy. Members: James I. Healy (chair, current); John Maraganore (member, current); Raymond Sanchez (member, current); Robert J. Perez (member, current). committee_id=alpha:committee:rapport-therapeutics-inc:compensation-committee
- nominating and corporate governance committee (nominating_governance). Chair: Robert J. Perez. Members: Robert J. Perez (chair, current); Steven M. Paul (member, current). committee_id=alpha:committee:rapport-therapeutics-inc:nominating-and-corporate-governance-committee
- science and technology committee (technology). Chair: Wendy B. Young. Members: Wendy B. Young (chair, current); Raymond Sanchez (member, current); Reid Huber (member, current); Steven M. Paul (member, current). committee_id=alpha:committee:rapport-therapeutics-inc:science-and-technology-committee

## Executive leadership

- Abraham N. Ceesay, M.B.A.: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:13
- Cheryl Gault: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:14
- David Bredt, M.D., Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:15
- Jeffrey Sevigny, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:16
- Swamy Yeleswaram, Ph.D.: Chief Development Officer. Status: current. claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:17
- Troy Ignelzi: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:18

## Governance events

- DIRECTOR_APPOINTED: Steven M. Paul seat on Rapport Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:1fligzazgm9qu
- CEO_CHANGED: Abraham N. Ceesay, M.B.A. executive of Rapport Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:sicvkn1dymg7z
- EXECUTIVE_APPOINTED: Cheryl Gault executive of Rapport Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:cqthollsuf5
- EXECUTIVE_APPOINTED: David Bredt, M.D., Ph.D. executive of Rapport Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:6ib1mfy9su6b
- EXECUTIVE_APPOINTED: Jeffrey Sevigny, M.D. executive of Rapport Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:13tcslzqcbssd
- EXECUTIVE_APPOINTED: Swamy Yeleswaram, Ph.D. executive of Rapport Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:1dwu4mm1vh29d4
- CFO_CHANGED: Troy Ignelzi executive of Rapport Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:1pe6qsuq5rc8u
- DIRECTOR_APPOINTED: John Maraganore seat on Rapport Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:191plx41kjdv36
- DIRECTOR_APPOINTED: Raymond Sanchez seat on Rapport Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:m1z4ol1w0qmld
- DIRECTOR_APPOINTED: Robert J. Perez seat on Rapport Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:16lqzou1iwsyx0
- DIRECTOR_APPOINTED: Wendy B. Young seat on Rapport Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:1lvg1pe18oiole
- DIRECTOR_APPOINTED: Abraham N. Ceesay, M.B.A. seat on Rapport Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:6vfayx10k11wv
- DIRECTOR_APPOINTED: James I. Healy seat on Rapport Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:14u9ntosqaa00
- DIRECTOR_APPOINTED: Reid Huber seat on Rapport Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:07.749004+00:00. event_id=alpha:event:transition:l6sh84jt8voy

## Scoped resources

- `alpha://company/rapport-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record
- `alpha://company/rapport-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=identity
- `alpha://company/rapport-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/rapport-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=board
- `alpha://company/rapport-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=committees
- `alpha://company/rapport-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=leadership
- `alpha://company/rapport-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=ownership
- `alpha://company/rapport-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=financials
- `alpha://company/rapport-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/rapport-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=compensation
- `alpha://company/rapport-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=governance
- `alpha://company/rapport-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/rapport-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=audit
- `alpha://company/rapport-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=legal
- `alpha://company/rapport-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=risk
- `alpha://company/rapport-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=cyber
- `alpha://company/rapport-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/rapport-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=agents
- `alpha://company/rapport-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/rapport-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=events
- `alpha://company/rapport-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=relationships
- `alpha://company/rapport-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=assessments
- `alpha://company/rapport-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:20: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE","category":"audit","role":"member","person":{"alpha_id":"alpha:person:james-i-healy-rapp","name":"James I. Healy"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:21: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE","category":"audit","role":"member","person":{"alpha_id":"alpha:person:john-maraganore-rapp","name":"John Maraganore"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:23: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:james-i-healy-rapp","name":"James I. Healy"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:24: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:john-maraganore-rapp","name":"John Maraganore"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:25: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:raymond-sanchez-rapp","name":"Raymond Sanchez"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:26: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:robert-j-perez-rapp","name":"Robert J. Perez"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:28: `{"kind":"committee_appointment","original_name":"nominating and corporate governance committee","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:robert-j-perez-rapp","name":"Robert J. Perez"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:29: `{"kind":"committee_appointment","original_name":"nominating and corporate governance committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:steven-m-paul-rapp","name":"Steven M. Paul"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:31: `{"kind":"committee_appointment","original_name":"science and technology committee","category":"technology","role":"chair","person":{"alpha_id":"alpha:person:wendy-b-young-rapp","name":"Wendy B. Young"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:32: `{"kind":"committee_appointment","original_name":"science and technology committee","category":"technology","role":"member","person":{"alpha_id":"alpha:person:raymond-sanchez-rapp","name":"Raymond Sanchez"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:33: `{"kind":"committee_appointment","original_name":"science and technology committee","category":"technology","role":"member","person":{"alpha_id":"alpha:person:reid-huber-rapp","name":"Reid Huber"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:34: `{"kind":"committee_appointment","original_name":"science and technology committee","category":"technology","role":"member","person":{"alpha_id":"alpha:person:steven-m-paul-rapp","name":"Steven M. Paul"},"source_id":"governance_people_committees"}`

## Leadership

- Abraham N. Ceesay, M.B.A.: Director. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:5. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:970aedea02b53b751aa6c671a851a0dd819bb8e5d7d348e5540c5b186e1eb75b.
- James I. Healy: Director. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:970aedea02b53b751aa6c671a851a0dd819bb8e5d7d348e5540c5b186e1eb75b.
- John Maraganore: Director. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:7. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:970aedea02b53b751aa6c671a851a0dd819bb8e5d7d348e5540c5b186e1eb75b.
- Raymond Sanchez: Director. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:970aedea02b53b751aa6c671a851a0dd819bb8e5d7d348e5540c5b186e1eb75b.
- Reid Huber: Director. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:9. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:970aedea02b53b751aa6c671a851a0dd819bb8e5d7d348e5540c5b186e1eb75b.
- Robert J. Perez: Director. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:970aedea02b53b751aa6c671a851a0dd819bb8e5d7d348e5540c5b186e1eb75b.
- Steven M. Paul: Director. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:11. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:970aedea02b53b751aa6c671a851a0dd819bb8e5d7d348e5540c5b186e1eb75b.
- Wendy B. Young: Director. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:12. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:970aedea02b53b751aa6c671a851a0dd819bb8e5d7d348e5540c5b186e1eb75b.
- Abraham N. Ceesay, M.B.A.: Chief Executive Officer and Director. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:13. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66ce880a7fa06cfa4620bc66f163f48c336015da3e314a5619cd8919301ec9f9.
- Cheryl Gault: Chief Operating Officer. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:14. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0aaf1a9b5d82c6f552623367f630750bdb6e75f9eaca2b68350b3a481b722a18.
- David Bredt, M.D., Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:15. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:76bc7cca07164d5e8b8ec0e9f52a2806f45a8c4f4d13351b01a92f107888dfbe.
- Jeffrey Sevigny, M.D.: Chief Medical Officer. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:16. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:26a912896de89a911e2333255342323bc1dd5fb5cf12c7ed967825dced846099.
- Swamy Yeleswaram, Ph.D.: Chief Development Officer. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:17. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b27d212624519ae3e664cad9e852709d82007972367ae1dff769c7dd1d46b09e.
- Troy Ignelzi: Chief Financial Officer. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:leadership_role:18. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:47f1c054591b9b90f35236d02d01f16629a212c7f3bad46b53f26fa5651fcfc5.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- AUDIT COMMITTEE: Chair not stated; Members James I. Healy; John Maraganore. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- compensation committee: Chair James I. Healy; Members James I. Healy (Chair); John Maraganore; Raymond Sanchez; Robert J. Perez. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- nominating and corporate governance committee: Chair Robert J. Perez; Members Robert J. Perez (Chair); Steven M. Paul. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_record:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- science and technology committee: Chair Wendy B. Young; Members Wendy B. Young (Chair); Raymond Sanchez; Reid Huber; Steven M. Paul. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_record:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Rapport Therapeutics, Inc.. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e42a65a7980262c176d33d3581c53a74f61c29db8597ff813a67fd148e05fed0.

## Entity Status

- Public listing published. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e42a65a7980262c176d33d3581c53a74f61c29db8597ff813a67fd148e05fed0.

## Published Fact

- US. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e42a65a7980262c176d33d3581c53a74f61c29db8597ff813a67fd148e05fed0.

## Committee Appointment

- James I. Healy: member, AUDIT COMMITTEE. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- John Maraganore: member, AUDIT COMMITTEE. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- James I. Healy: chair, compensation committee. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- John Maraganore: member, compensation committee. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- Raymond Sanchez: member, compensation committee. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- Robert J. Perez: member, compensation committee. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- Robert J. Perez: chair, nominating and corporate governance committee. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- Steven M. Paul: member, nominating and corporate governance committee. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- Wendy B. Young: chair, science and technology committee. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- Raymond Sanchez: member, science and technology committee. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- Reid Huber: member, science and technology committee. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.
- Steven M. Paul: member, science and technology committee. Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6.

## Security Listing

- RAPP (NASDAQ). Claim: alpha:claim:company:50a4c05a-141e-48a0-884a-b2f92b1d0aad:security_listing:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e42a65a7980262c176d33d3581c53a74f61c29db8597ff813a67fd148e05fed0.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:e42a65a7980262c176d33d3581c53a74f61c29db8597ff813a67fd148e05fed0: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/rapport-therapeutics-inc).
- alpha:projection-evidence:document:970aedea02b53b751aa6c671a851a0dd819bb8e5d7d348e5540c5b186e1eb75b: [DEF 14A d35380ddef14a.htm](https://www.sec.gov/Archives/edgar/data/2012593/000119312526171828/d35380ddef14a.htm).
- alpha:projection-evidence:document:66ce880a7fa06cfa4620bc66f163f48c336015da3e314a5619cd8919301ec9f9: [RAPP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/2012593/000119312526171828/d35380ddef14a.htm).
- alpha:projection-evidence:document:0aaf1a9b5d82c6f552623367f630750bdb6e75f9eaca2b68350b3a481b722a18: [RAPP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/2012593/000119312526171828/d35380ddef14a.htm).
- alpha:projection-evidence:document:76bc7cca07164d5e8b8ec0e9f52a2806f45a8c4f4d13351b01a92f107888dfbe: [RAPP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/2012593/000119312526171828/d35380ddef14a.htm).
- alpha:projection-evidence:document:26a912896de89a911e2333255342323bc1dd5fb5cf12c7ed967825dced846099: [RAPP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/2012593/000119312526171828/d35380ddef14a.htm).
- alpha:projection-evidence:document:b27d212624519ae3e664cad9e852709d82007972367ae1dff769c7dd1d46b09e: [RAPP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/2012593/000119312526171828/d35380ddef14a.htm).
- alpha:projection-evidence:document:47f1c054591b9b90f35236d02d01f16629a212c7f3bad46b53f26fa5651fcfc5: [RAPP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/2012593/000119312526171828/d35380ddef14a.htm).
- alpha:projection-evidence:a1dc6e6d2963efe941313738cf6aa249d6ce0cca3c3919bb0836cd3cc9e80bd6: [AUDIT COMMITTEE](https://www.sec.gov/Archives/edgar/data/2012593/000119312526171828/d35380ddef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/rapport-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/rapport-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/rapport-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/rapport-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-17T06:11:08.628238+00:00; recorded 2026-10-17T06:11:08.628238+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.